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Experimental setup 
 
Our hyperspectral SRS microscope (Figure S1a) employed a 
dual output femtosecond pulse laser (InSight DeepSee, 
Spectra-Physics, Mountain View, CA) with a repetition rate 
at 80 MHz. The 120-fs tunable laser was tuned to 883 nm, 
served as the pump beam   . The other 220-fs laser with 
fixed power of 500 mW and wavelength of 1040 nm was 
used as the Stokes beam   . For heterodyne detection, the 
Stokes beam intensity was modulated by an acousto-optical 
modulator (AOM, 1205-C, Isomet, Springfield, VA) at 2.25 
MHz. The pulse shaping technology
[1]
 was employed for 
intra-pulse spectral manipulation. One 4f pulse shaper was 
installed in the Stokes beam to narrow down the spectral 
width of the 220-fs laser. After the optical modulator and the 
pulse shaper, full width at half maximum (FWHM) of the 
pulse was measured to be 2.3 ps by an autocorrelator and the 
laser power was measured to be 50 mW. Another 4f pulse 
shaper was installed in the pump beam for intra-pulse 
wavelength scanning with a motorized translation stage (T-
LS28E, Zaber, Vancouver, Canada) at the Fourier plane of 
the pulse shaper. By controlling the slit width, a spectral 
FWHM width of ~0.2 nm was obtained for the pump beam 
(Figure S1b). The maximum pump beam power was 50 mW, 
measured at 883 nm. The pump and Stokes beams were 
collinearly combined and directed into a homebuilt laser 
scanning upright microscope. A water immersion objective 
lens (UPlanSApo, Olympus, Tokyo, Japan) with numerical 
aperture of 1.2 focused the lasers into the sample. The 
photons were collected by an oil condenser (NA=1.4). The 
pump beam was selected by two bandpass filters 
(HQ825/150m, Chroma, Bellows Falls, VT), and was 
detected by a photodiode (S3994-01, Hamamatsu, Japan) 
equipped with a resonant circuit
[2]
 that selectively amplifies 
the signal at the optical modulation frequency. The 
stimulated Raman loss signal was then extracted by a digital 
lock-in amplifier (HF2LI, Zurich Instrument, Zurich, 
Switzerland).
[3]
 The DC output voltage from the resonant 
circuit, which represents the laser power, and the X channel 
voltage from the lock-in amplifier, which represents the SRS 
signal, were sampled by a DAQ card (PCI 6251, National 
Instruments, Austin, TX). A Labview platform synchronized 
scanning of wavelength with stacking of XY-Ω (Ω: Raman 
shift) images. Hyperspectral SRS imaging was performed by 
varying Raman shift from 1620 to 1800 cm
-1
, which covers 
the acyl and sterol C=C stretch bands in lipid, the amide I 
band in protein, and the C=O band in ester. The estimated the 
spectral resolution of our system is 12 cm
-1
. Each SRS image 
contained 200 x 200 pixels. The pixel dwell time was 10 μs 
for phantoms, 20 μs for emulsions, and 40 µs per pixel for 
arteries.  
 
Specimen preparation 
 
Pure cholesterol crystal (Sigma Grade, ≥ 99%), glyceryl 
trioleate (Sigma Grade, ≥ 99%) and BSA were purchased 
from Sigma-Aldrich (St. Louis, MO). A droplet of glyceryl 
trioleate oil, cholesterol crystal and BSA powder were mixed 
and sealed between two glass coverslips right before SRS 
imaging. 
Lipid droplet emulsions were prepared by solvent 
evaporation method. Briefly, cholesteryl oleate (Sigma) and 
glyceryl trioleate were both dissolved in acetone at the same 
concentration (10 mM). The cholesteryl oleate and glyceryl 
trioleate solutions were mixed together at various volume 
ratios. The mixtures were added to deionized water at a 
volume ratio of 1:20, supplemented with 0.05% Tween-20 
surfactant. Lipid droplets formed during magnetic stirring for 
10 min. A drop of emulsion was sandwiched between two 
glass coverslips and sealed right before imaging.  
Atherosclerotic arteries were harvested from metabolic 
syndrome Ossabaw pigs. Briefly, the pigs were fed 
hypercaloric, atherogenic diet composed of 2% cholesterol, 
20% kcal from fructose, and 43% kcal from hydrogenated 
soybean oil, coconut oil, and lard.
[4]
 Carotid arteries with 
atherosclerotic plaque were harvested and preserved in 10% 
phosphate-buffered formalin after being cut to 50 µm thick 
sections. The artery slices were washed with phosphate-
buffered saline and then sandwiched between two glass 
coverslips before SRS imaging.  
 
MCR algorithm    
 
MCR
[5]
 is a bilinear model capable of decomposing a 
measured spectral data set D into concentration profiles and 
spectra of chemical components, represented by matrices C 
and S
T
, 
                                D = C·S
T 
+ E.                (1) 
Here, T means the transpose of matrix of S. E is the 
residual matrix or experimental error. The input to MCR is 
the dataset D and the reference spectra of each component. S 
contains the output spectra of all fitted components. The 
output concentration of a chemical component at each pixel 
is expressed as percentage relative to the intensity of the 
MCR optimized spectrum. Giving initial estimate of pure 
spectra either from principal component analysis or prior 
knowledge, an alternating least squares algorithm calculates 
C and S by Eq. (1) iteratively until the results optimally fit 
the data matrix D. Non negativity on both concentration and 
spectra profiles is applied as a constraint during the 
alternating least squares iteration.  
Data augmentation was applied for cholesteryl ester 
quantification to reduce ambiguity associated with MCR 
decomposition.
[5d]
 The augmentation matrix composed of 
repeating SRS spectra of acyl C=C, sterol C=C and ester 
group C=O bands was added to spectral dataset D. The 
enhanced weight on pure reference spectra ensured MCR 
algorithm to selectively recover concentration profiles for 
corresponding Raman bands from experimental dataset D. 
The flow chart of MCR can be found in supplementary 
Figure S2. 
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Supplementary Figures  
 
 
 
 
Figure S1. Experimental setup. a) Schematic of hyperspectral stimulated Raman scattering microscope. DC: 
Dichroic combiner; SU: Scanning unit; OB: Objective; OC: Oil condenser; F: Bandpass filter; PD: Photodiode. b) 
Spectra of pump beam measured after the intra-pulse scanning pulse shaper.  
 
 
Figure S2. MCR flow chart. The hyperspectral SRS image stack is unfolded into a two dimensional (2-D) data 
matrix D and combines with augmentation data as MCR input. Giving initial estimation of spectra, ALS algorithm 
decomposes data matrix D into concentration matrix C and corresponding spectra profiles S
T 
for q components. 
Here, q is the number of components. The matrix C is then refolded to concentration maps for each component.  
 
  
Figure S3. Spontaneous Raman spectra of glyceryl trioleate and cholesteryl oleate emulsions. Dotted line indicates 
the Raman shift position of acyl C=C bond.  
 
Supplementary Videos: 
Movie S1. Hyperspectral SRS image stack of cholesterol, triglyceride and BSA mixture. The field of view of the 
movie is 240 µm × 240 µm. 
Movie S2. Hyperspectral SRS image stack of atherosclerotic artery tissue harvested from Ossabaw pigs. The field 
of view of the movie is 140 µm × 140 µm. 
Movie S3. Hyperspectral SRS image stack of atherosclerotic artery tissue where abundant LDs was found. The 
field of view of the movie is 100 µm × 100 µm. 
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